Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Iterum Therapeutics plc - Ordinary Share
(NQ:
ITRM
)
0.1710
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Iterum Therapeutics plc - Ordinary Share
< Previous
1
2
3
4
5
Next >
These stocks are moving in today's after hours session
↗
March 03, 2026
Via
Chartmill
What's going on in today's session
↗
March 03, 2026
Via
Chartmill
These stocks are moving in today's session
↗
March 03, 2026
Via
Chartmill
Which stocks are gapping on Tuesday?
↗
March 03, 2026
Via
Chartmill
Earnings Scheduled For August 5, 2025
↗
August 05, 2025
Via
Benzinga
Insights Ahead: Iterum Therapeutics's Quarterly Earnings
↗
August 04, 2025
Via
Benzinga
A Look Ahead: Iterum Therapeutics's Earnings Forecast
↗
May 12, 2025
Via
Benzinga
A Look at Iterum Therapeutics's Upcoming Earnings Report
↗
November 13, 2024
Via
Benzinga
Which stocks are moving before the opening bell on Tuesday?
↗
March 03, 2026
Via
Chartmill
Wondering what's happening in today's after-hours session?
↗
December 31, 2025
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
November 18, 2025
Via
Benzinga
Iterum Therapeutics (ITRM) Earnings Transcript
↗
November 14, 2025
Iterum Therapeutics (ITRM) Earnings Transcript
Via
The Motley Fool
Topics
Intellectual Property
Iterum Therapeutics PLC (NASDAQ:ITRM) Stock Plummets on Wider-Than-Expected Q3 Loss
↗
November 14, 2025
Iterum Therapeutics stock plunges after Q3 2025 earnings miss estimates, with a wider-than-expected loss overshadowing its new product launch.
Via
Chartmill
Topics
Earnings
Earnings Scheduled For November 14, 2025
↗
November 14, 2025
Via
Benzinga
A Glimpse of Iterum Therapeutics's Earnings Potential
↗
November 13, 2025
Via
Benzinga
Top Stocks With Earnings This Week: Plug, Oklo, Circle And More
↗
November 10, 2025
Here's a look at this week's earnings reports that are most likely to be watched by retail investors, including Oklo, Plug and Circle.
Via
Benzinga
ITRM Reports Results
↗
August 05, 2025
Via
The Motley Fool
Topics
Intellectual Property
Iterum Therapeutics PLC (NASDAQ:ITRM) Reports Wider Q2 2025 Loss, Market Optimistic Ahead of ORLYNVAH Launch
↗
August 05, 2025
Iterum Therapeutics PLC reports Q2 2025 earnings with a wider loss than expected, but stock rises 4.15% pre-market as investors anticipate ORLYNVAH's August 2025 launch. Cash reserves extend into...
Via
Chartmill
Which stocks are moving after the closing bell on Monday?
↗
August 04, 2025
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
July 23, 2025
Via
Benzinga
Top movers in Tuesday's pre-market session
↗
April 29, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
April 29, 2025
Via
Benzinga
Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday?
↗
February 07, 2025
Wall Street slumped into negative territory late in the week as renewed fears over inflation and trade tariffs eroded risk appetite.
Via
Benzinga
Topics
Economy
World Trade
Earnings Scheduled For February 7, 2025
↗
February 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
December 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 28, 2024
Via
Benzinga
FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships
↗
October 28, 2024
Iterum Therapeutics' Orlynvah receives FDA approval for treating uncomplicated UTIs in adult women, marking its first approved indication and a U.S. first for oral penems.
Via
Benzinga
Earnings Scheduled For November 14, 2024
↗
November 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 25, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
